A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. (Q52846360)
Jump to navigation
Jump to search
scientific article published on 14 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. |
scientific article published on 14 January 2011 |
Statements
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. (English)
Julia Brown
1 reference
Claire Dearden
1 reference
Andrew Pettitt
Hazem A Sayala
Christopher Fegan
NCRI CLL Sub-Group
Peter Hillmen
Daniel B Kennedy
Don W Milligan
Jane Mercieca
Raphael Ezekwisili
Alexandra F Smith
Gillian A Booth
Abraham M Varghese
Christopher Pocock
14 January 2011
152
5
570-578
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference